Robert Andrade - 28 Jun 2023 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Signature
/s/ Robert Andrade
Issuer symbol
FENC
Transactions as of
28 Jun 2023
Net transactions value
-$223,325
Form type
4
Filing time
30 Jun 2023, 16:21:11 UTC
Previous filing
03 Apr 2023
Next filing
05 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common shares Sale $89,900 -10,000 -6.7% $8.99 139,721 28 Jun 2023 Direct F1
transaction FENC Common shares Sale $67,275 -7,500 -5.4% $8.97 132,221 29 Jun 2023 Direct F2
transaction FENC Common shares Sale $66,150 -7,500 -5.7% $8.82 124,721 30 Jun 2023 Direct F3
transaction FENC Common shares Options Exercise $61,250 +25,000 +20% $2.45 149,721 30 Jun 2023 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Common Shares Options Exercise $61,250 -25,000 -4% $2.45 605,000 30 Jun 2023 Options 25,000 $2.45 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents shares sold pursuant to a 10b5-1 plan on June 28, 2023.
F2 Represents shares sold pursuant to a 10b5-1 plan on June 29, 2023.
F3 Represents shares sold pursuant to a 10b5-1 plan on June 30, 2023.
F4 Shares aquired through the exercise of option contract with a strike price of $2.45 and an expiration date of July 5, 2026.
F5 Represents options granted on July 5, 2016, with a strike price of $2.45 and expiration date of July 5, 2026.